Tumor-targeted silencing of the peptide transporter TAP induces potent antitumor immunity
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tumor-targeted silencing of the peptide transporter TAP induces potent antitumor immunity
Authors
Keywords
-
Journal
Nature Communications
Volume 10, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-08-21
DOI
10.1038/s41467-019-11728-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control
- (2018) Jan P. Böttcher et al. CELL
- Immune Checkpoint Blockade across the Cancer Care Continuum
- (2018) Beth A. Helmink et al. IMMUNITY
- TEIPP antigens for T-cell based immunotherapy of immune-edited HLA class I low cancers
- (2018) Koen A. Marijt et al. MOLECULAR IMMUNOLOGY
- Update on Tumor Neoantigens and Their Utility: Why It Is Good to Be Different
- (2018) Chung-Han Lee et al. TRENDS IN IMMUNOLOGY
- Identification of non-mutated neoantigens presented by TAP-deficient tumors
- (2018) Koen A. Marijt et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The Link between the Multiverse of Immune Microenvironments in Metastases and the Survival of Colorectal Cancer Patients
- (2018) Marc Van den Eynde et al. CANCER CELL
- Evolution of Metastases in Space and Time under Immune Selection
- (2018) Mihaela Angelova et al. CELL
- Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth
- (2017) Giovanni Germano et al. NATURE
- In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target
- (2017) Robert T. Manguso et al. NATURE
- Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
- (2017) Dung T. Le et al. SCIENCE
- T cells specific for a TAP-independent self-peptide remain naïve in tumor-bearing mice and are fully exploitable for therapy
- (2017) Elien M. Doorduijn et al. OncoImmunology
- Neoantigens encoded in the cancer genome
- (2016) Ton N Schumacher et al. CURRENT OPINION IN IMMUNOLOGY
- Recent advances in viral evasion of the MHC Class I processing pathway
- (2016) Anouk BC Schuren et al. CURRENT OPINION IN IMMUNOLOGY
- Tumor-Specific T Cell Dysfunction Is a Dynamic Antigen-Driven Differentiation Program Initiated Early during Tumorigenesis
- (2016) Andrea Schietinger et al. IMMUNITY
- TAP-independent self-peptides enhance T cell recognition of immune-escaped tumors
- (2016) Elien M. Doorduijn et al. JOURNAL OF CLINICAL INVESTIGATION
- Neoantigen landscape dynamics during human melanoma–T cell interactions
- (2016) Els M. E. Verdegaal et al. NATURE
- Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
- (2016) N. McGranahan et al. SCIENCE
- Targeting of cancer neoantigens with donor-derived T cell receptor repertoires
- (2016) E. Stronen et al. SCIENCE
- A Novel Immunocompetent Mouse Model of Pancreatic Cancer with Robust Stroma: a Valuable Tool for Preclinical Evaluation of New Therapies
- (2015) Kaustav Majumder et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
- (2015) N. A. Rizvi et al. SCIENCE
- Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing
- (2014) Mahesh Yadav et al. NATURE
- Mitigating the toxic effects of anticancer immunotherapy
- (2014) Tara C. Gangadhar et al. Nature Reviews Clinical Oncology
- Targeting 4-1BB Costimulation to the Tumor Stroma with Bispecific Aptamer Conjugates Enhances the Therapeutic Index of Tumor Immunotherapy
- (2014) B. Schrand et al. Cancer Immunology Research
- Monitoring peptide processing for MHC class I molecules in the endoplasmic reticulum
- (2013) Nilabh Shastri et al. CURRENT OPINION IN IMMUNOLOGY
- New Role of Signal Peptide Peptidase To Liberate C-Terminal Peptides for MHC Class I Presentation
- (2013) C. C. Oliveira et al. JOURNAL OF IMMUNOLOGY
- High-throughput identification of antigen-specific TCRs by TCR gene capture
- (2013) Carsten Linnemann et al. NATURE MEDICINE
- A Preclinical Evaluation of Minnelide as a Therapeutic Agent Against Pancreatic Cancer
- (2012) R. Chugh et al. Science Translational Medicine
- Thermal Stability of siRNA Modulates Aptamer- conjugated siRNA Inhibition
- (2012) Alexey Berezhnoy et al. Molecular Therapy-Nucleic Acids
- Peptide transporter TAP mediates between competing antigen sources generating distinct surface MHC class I peptide repertoires
- (2011) Cláudia C. Oliveira et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Different Expression Levels of the TAP Peptide Transporter Lead to Recognition of Different Antigenic Peptides by Tumor-Specific CTL
- (2011) A. Durgeau et al. JOURNAL OF IMMUNOLOGY
- A New Paradigm for Aptamer Therapeutic AS1411 Action: Uptake by Macropinocytosis and Its Stimulation by a Nucleolin-Dependent Mechanism
- (2010) E. M. Reyes-Reyes et al. CANCER RESEARCH
- CD8+ T Cell Responses against TAP-Inhibited Cells Are Readily Detected in the Human Population
- (2010) M. H. Lampen et al. JOURNAL OF IMMUNOLOGY
- Induction of tumour immunity by targeted inhibition of nonsense-mediated mRNA decay
- (2010) Fernando Pastor et al. NATURE
- Surface Expressed Nucleolin Is Constantly Induced in Tumor Cells to Mediate Calcium-Dependent Ligand Internalization
- (2010) Ara G. Hovanessian et al. PLoS One
- The nonpolymorphic MHC Qa-1bmediates CD8+T cell surveillance of antigen-processing defects
- (2009) Cláudia C. Oliveira et al. JOURNAL OF EXPERIMENTAL MEDICINE
- BrafV600E cooperates with Pten loss to induce metastatic melanoma
- (2009) David Dankort et al. NATURE GENETICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search